Alaunos Therapeutics, Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $70.9M | $81.1M | $140.7M | $42.8M | $68.2M | $73.3M | $104.7M | $60.4M |
| Accounts Receivable | $19.0K | $21.0K | $446.0K | $145.0K | $145.0K | $58.0K | $79.0K | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $90.8M | $104.9M | $152.5M | $44.1M | $70.3M | $80.3M | $106.1M | $60.8M |
| Property, Plant & Equipment | $1.2M | $843.0K | $581.0K | $531.0K | $801.0K | $2.0M | $1.1M | $253.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $105.6M | $106.3M | $153.7M | $45.2M | $71.8M | $83.4M | $108.1M | $61.5M |
| Liabilities | ||||||||
| Accounts Payable | $4.4M | $156.0K | $2.0M | $2.0M | $422.0K | $1.5M | $1.7M | $1.0M |
| Total Current Liabilities | $20.9M | $15.8M | $18.1M | $10.8M | $7.8M | $18.9M | $13.4M | $3.6M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $58.4M | $58.3M | $66.4M | $11.4M | $22.4M | $35.0M | $36.5M | $31.0M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-712.4M | $-658.0M | $-492.7M | $-372.6M | $-340.8M | $-283.7M | — | — |
| Total Stockholders' Equity | $-96.8M | $-77.3M | $87.4M | $33.8M | $49.4M | $48.4M | $71.6M | $30.6M |